Skip to content
1 active filter

News & Announcements

November 23 2023

Shingrix vaccine roll-out

From 1 November 2023, the varicella virus recombinant vaccine, Shingrix ®, replaces Zostavax®, on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It is available for eligible people most at risk of complications from shingles (1). The program changes follow recommendations from the Pharmaceutical Benefits Advisory Committee, the Australian Technical Advisory Group on Immunisation (ATAGI) and other clinical experts (1).

Learn more about Shingrix vaccine roll-out
October 07 2023

Research Opportunity - Knowledge, attitudes and current practice survey about long-acting reversible contraception and early medical abortion in primary care.

The aim of the study is to describe the levels of knowledge, attitudes and current practice (KAP) amongst general practitioners (GPs) and practice nurses (PNs) working in general practice, as well as community pharmacists (CPs) regarding long acting reversible contraception (LARC) and early medical abortion (EMA).

Learn more about Research Opportunity - Knowledge, attitudes and current practice survey about long-acting reversible contraception and early medical abortion in primary care.
Health Professionals, stay up to date with the latest PHN news in your region
Subscribe to our newsletter